[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

September 2019 - January 1920

Decade

Year

Issue

May 2016, Vol 152, No. 5, Pages 501-592

In This Issue of JAMA Dermatology

Highlights

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):501. doi:10.1001/jamadermatol.2015.3254
Viewpoint

The US Food and Drug Administration’s Proposed Rule to Increase Regulation of Indoor Tanning Devices

Abstract Full Text
JAMA Dermatol. 2016;152(5):509-510. doi:10.1001/jamadermatol.2016.0504

This Viewpoint discusses potential implications of the age and risk certification restrictions proposed by the US Food and Drug Administration in response to the US Surgeon General’s 2014 call to action to prevent skin cancer.

New Sunscreens and the Precautionary Principle

Abstract Full Text
JAMA Dermatol. 2016;152(5):511-512. doi:10.1001/jamadermatol.2015.6069

This Viewpoint explores the potential health benefit of ultraviolet radiation filter ingredients for sunscreen, and whether these new sunscreens, if introduced to the US market, should carry a different claim to those currently available in the United States.

Transgender Patients, Isotretinoin, and US Food and Drug Administration–Mandated Risk Evaluation and Mitigation Strategies: A Prescription for Inclusion

Abstract Full Text
JAMA Dermatol. 2016;152(5):513-514. doi:10.1001/jamadermatol.2015.5547

This Viewpoint discusses initiatives to improve health care for transgender persons, including gender-neutral practice that would help ensure their access to important medications.

Editorial

Are You Ready for Maintenance of Certification Self-Assessment 2.0?It’s Here, It’s Cheaper, and It’s Easier

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):515-516. doi:10.1001/jamadermatol.2016.0877

Genotypic Heterogeneity and the Mode of Inheritance in Epidermolysis Bullosa

Abstract Full Text
JAMA Dermatol. 2016;152(5):517-520. doi:10.1001/jamadermatol.2015.5237

Hedgehog Blockade for Basal Cell Carcinoma: Coming at a (Secondary Neoplastic) Price

Abstract Full Text
JAMA Dermatol. 2016;152(5):521-523. doi:10.1001/jamadermatol.2015.5239
Original Investigation

Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):527-532. doi:10.1001/jamadermatol.2015.4330

This case-control study evaluates the risk of developing a non–basal cell carcinoma malignancy after smoothened inhibitor exposure in patients with basal cell carcinoma.

Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):533-540. doi:10.1001/jamadermatol.2015.5548

This cohort study compares second posttransplant skin cancer formation after development of an index posttransplant cancer of any type in a group of organ transplant recipients who were or were not treated with sirolimus.

Association of Rosacea With Risk for Glioma in a Danish Nationwide Cohort Study

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):541-545. doi:10.1001/jamadermatol.2015.5549

This nationwide cohort study investigates the association between rosacea and the risk for glioma in a population of adults in Denmark.

Association of Shiny White Blotches and Strands With Nonpigmented Basal Cell Carcinoma: Evaluation of an Additional Dermoscopic Diagnostic Criterion

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):546-552. doi:10.1001/jamadermatol.2015.5731

This study examines the diagnostic accuracy of various types of shiny white structures in the diagnosis of basal cell carcinoma.

Factors Associated With Point-of-Care Treatment Decisions for Hidradenitis Suppurativa

Abstract Full Text
free access has audio
JAMA Dermatol. 2016;152(5):553-557. doi:10.1001/jamadermatol.2015.4593

This retrospective cohort analysis identifies clinical and demographic factors that patients and clinicians may consider in developing partnered short- and long-term treatment strategies for hidradenitis suppurativa.

Case Report/Case Series

Heterozygosity for a Novel Missense Mutation in the ITGB4 Gene Associated With Autosomal Dominant Epidermolysis Bullosa

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):558-562. doi:10.1001/jamadermatol.2015.5236

This case report describes a dominant mode of inheritance for a missense ITGB4 mutation in epidermolysis bullosa.

JAMA Dermatology Clinical Evidence Synopsis

Screening Recommendations for Hepatitis B Virus Infection

Abstract Full Text
JAMA Dermatol. 2016;152(5):565-566. doi:10.1001/jamadermatol.2015.4688

This Evidence Synopsis reviews the screening recommendations for hepatitis B virus infection.

JAMA Dermatology Clinicopathological Challenge

Friable Nodules on the Elbow of a Transplant Patient

Abstract Full Text
JAMA Dermatol. 2016;152(5):567-568. doi:10.1001/jamadermatol.2015.5730

An immunosuppressed man in his 60s was admitted for hypertensive urgency, and a dermatologist was consulted during his admission to evaluate a friable, growing lesion on his right elbow that had appeared 2 months prior. What is your diagnosis?

Erythematous Papules and Plaques on the Cheeks

Abstract Full Text
JAMA Dermatol. 2016;152(5):569-570. doi:10.1001/jamadermatol.2015.5252

A man presented with a 3-year history of recurring erythematous papules on the bilateral cheeks, despite topical steroid therapy, without any additional symptoms. Polyclonal hypergammaglobulinemia was found on serum protein electrophoresis. What is your diagnosis?

Acute Presentation of Tender Papules and Plaques in a Patient With Leukemia

Abstract Full Text
JAMA Dermatol. 2016;152(5):571-572. doi:10.1001/jamadermatol.2015.5253

A woman with acute myeloid leukemia was admitted with blast crisis and tumor lysis syndrome; flow cytometry showed myeloid blasts, most of which expressed CD13, CD33, CD117, and partial CD11b, and blasts were highly positive for myeloperoxidase. What is your diagnosis?

Research Letter

Histologic Evidence of Melanocytes Isolated to the Nail Matrix

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):573-575. doi:10.1001/jamadermatol.2015.5869

This analysis examines whether isolated pigmented lesions of the nail bed warrant consideration of causes other than subungual melanoma for their occurrence.

Associations Between Indoor Tanning and Substance Use Among Colorado High School Students

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):575-577. doi:10.1001/jamadermatol.2015.5663

This study analyzes results from a survey of Colorado high school students to examine state-level associations between substance use and indoor tanning.

The Association Between Psychiatric Disorders and Frequent Indoor Tanning

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):577-579. doi:10.1001/jamadermatol.2015.5866

This study assesses the prevalence of seasonal affective disorder, perceived stress, and body dysmorphic disorder in women who frequently use indoor tanning.

Hair and Scalp Care in African American Women Who Exercise

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):579-580. doi:10.1001/jamadermatol.2016.0093

This study surveys physically active black women to determine the most common hair care practices used to accommodate exercise, and seeks to provide recommendations for ideal regimens for hair and scalp care during and after exercise.

Observation

Cutaneous Presentation of Methicillin-Resistant Staphylococcus aureus Sepsis in a Healthy Child

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):580-582. doi:10.1001/jamadermatol.2015.5367

This case report describes the cutaneous presentation of methicillin-resistant Staphylococcus aureus sepsis in a healthy child.

Safe Use of Therapeutic-Dose Oral Isotretinoin in Patients With a History of Pseudotumor Cerebri

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):582-584. doi:10.1001/jamadermatol.2015.3447

This report of cases describes the safe and successful use of therapeutic-dose oral isotretinoin in 3 patients with a history of pseudotumor cerebri.

Melanoma Gene Expression Markers for Surveillance of Epidermolysis Bullosa Nevi Malignant Transformation

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):584-586. doi:10.1001/jamadermatol.2015.5702

This case report of a young girl with epidermolysis bullosa (EB) describes melanoma gene expression markers that aid in thorough histopathologic examination of suspicious EB nevi lesions.

Recurrent Richter’s Transformation Presenting With a Penile Ulcer

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):586-587. doi:10.1001/jamadermatol.2015.5708

This case report describes recurrent Richter’s transformation presenting with a penile ulcer.

Radiation Recall Dermatitis With Concomitant Dabrafenib and Pazopanib Therapy

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):587-589. doi:10.1001/jamadermatol.2015.5366

This case report describes the occurrence of radiation recall dermatitis associated with concomitant dabrafenib and pazopanib therapy.

Necrobiotic Xanthogranuloma Treated With Topical Nitrogen Mustard (Mechlorethamine)

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):589-590. doi:10.1001/jamadermatol.2015.5151

This case report describes necrobiotic xanthogranuloma treated with topical nitrogen mustard (mechlorethamine).

Inverse Psoriasiform Eruption During Pembrolizumab Therapy for Metastatic Melanoma

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):590-592. doi:10.1001/jamadermatol.2015.5210

This case report describes the occurrence of inverse psoriasiform eruption during pembrolizumab therapy for metastatic melanoma.

Correction

Author Middle Initial Omitted

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):592. doi:10.1001/jamadermatol.2016.1151
Notable Notes

Garbanzo-Icchen-Cowardly-Pox

Abstract Full Text
JAMA Dermatol. 2016;152(5):532. doi:10.1001/jamadermatol.2015.4443

The Salem Witch Trials—Bewitchment or Ergotism

Abstract Full Text
JAMA Dermatol. 2016;152(5):540. doi:10.1001/jamadermatol.2015.4863

Dermatologic Marvels—Hypertrichosis

Abstract Full Text
JAMA Dermatol. 2016;152(5):552. doi:10.1001/jamadermatol.2015.4846

Tumor Necrosis Factor and the Tenacious α

Abstract Full Text
JAMA Dermatol. 2016;152(5):557. doi:10.1001/jamadermatol.2015.4322

Beauty That Is More Than Skin Deep

Abstract Full Text
JAMA Dermatol. 2016;152(5):562-563. doi:10.1001/jamadermatol.2015.4762

The Hypertrichosis of Esau

Abstract Full Text
JAMA Dermatol. 2016;152(5):592. doi:10.1001/jamadermatol.2015.4355
JAMA Dermatology Masthead

JAMA Dermatology

Abstract Full Text
free access
JAMA Dermatol. 2016;152(5):504. doi:10.1001/jamadermatol.2015.3255
×